Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

U Rebmann

Showing results (21-30 of 32) with videos related to

Pageof 4
Sort By:
International Journal of Impotence Research|May 4, 2012
Erectile dysfunction after radical prostatectomy: the impact of nerve-sparing status and surgical approachN Koehler, S Holze, L Gansera, et al.
Zeitschrift Fur Experimentelle Chirurgie, Transplantation, Und Kunstliche Organe : Organ Der Sektion Experimentelle Chirurgie Der Gesellschaft Fur Chirurgie Der DDR|January 1, 1990
[The improvement of the tolerance of the kidney for ischemia with the prostacyclin analog iloprost]H J Forth, U Rebmann, H Heynemann, et al.
Zeitschrift Fur Urologie Und Nephrologie|December 1, 1986
[Effect of iloprost on aggregation behavior in kidney conditioning and changes in iloprost concentration in kidney preservation]U Rebmann, A Fahr, C Wachsmuth, et al.
International Journal of Cancer|December 22, 1999
Risk factors for relapse in stage I non-seminomatous germ-cell tumors: preliminary results of the German Multicenter Trial. German Testicular Cancer Study GroupP Albers, R Siener, M Hartmann, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|February 1, 1995
Multiinstitutional home-therapy trial of recombinant human interleukin-2 and interferon alfa-2 in progressive metastatic renal cell carcinomaJ Atzpodien, E Lopez Hänninen, H Kirchner, et al.
European Journal of Cancer Care|March 26, 2014
Psychological distress and adjustment to disease in patients before and after radical prostatectomy. Results of a prospective multi-centre studyN Köhler, M Friedrich, L Gansera, et al.
Journal of Cancer Research and Clinical Oncology|January 1, 1997
Concentrations of lysosomal cysteine proteases are decreased in renal cell carcinoma compared with normal kidneyH Kirschke, T Clausen, B Göhring, et al.
Annals of Oncology : Official Journal of the European Society for Medical Oncology|May 29, 1998
Recombinant human erythropoietin in the treatment of chemotherapy-induced anemia and prevention of transfusion requirement associated with solid tumors: a randomized, controlled studyC Oberhoff, B Neri, D Amadori, et al.
Der Urologe. Ausg. A|November 3, 2020
[Certified residency curriculum for the specialization training in urology from the German Society of Urology according to the 2018 Training Regulations (version of 20. September 2019)]M S Michel, M Himmler, U Necknig, et al.
British Journal of Cancer|August 16, 2006
Interleukin-2/interferon-alpha2a/13-retinoic acid-based chemoimmunotherapy in advanced renal cell carcinoma: results of a prospectively randomised trial of the German Cooperative Renal Carcinoma Chemoimmunotherapy Group (DGCIN)J Atzpodien, H Kirchner, U Rebmann, et al.
Pageof 4

Showing results (21-30 of 32) with videos related to

Sort By:
Pageof 4
International Journal of Impotence Research|May 4, 2012
Erectile dysfunction after radical prostatectomy: the impact of nerve-sparing status and surgical approachN Koehler, S Holze, L Gansera, et al.
Zeitschrift Fur Experimentelle Chirurgie, Transplantation, Und Kunstliche Organe : Organ Der Sektion Experimentelle Chirurgie Der Gesellschaft Fur Chirurgie Der DDR|January 1, 1990
[The improvement of the tolerance of the kidney for ischemia with the prostacyclin analog iloprost]H J Forth, U Rebmann, H Heynemann, et al.
Zeitschrift Fur Urologie Und Nephrologie|December 1, 1986
[Effect of iloprost on aggregation behavior in kidney conditioning and changes in iloprost concentration in kidney preservation]U Rebmann, A Fahr, C Wachsmuth, et al.
International Journal of Cancer|December 22, 1999
Risk factors for relapse in stage I non-seminomatous germ-cell tumors: preliminary results of the German Multicenter Trial. German Testicular Cancer Study GroupP Albers, R Siener, M Hartmann, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|February 1, 1995
Multiinstitutional home-therapy trial of recombinant human interleukin-2 and interferon alfa-2 in progressive metastatic renal cell carcinomaJ Atzpodien, E Lopez Hänninen, H Kirchner, et al.
European Journal of Cancer Care|March 26, 2014
Psychological distress and adjustment to disease in patients before and after radical prostatectomy. Results of a prospective multi-centre studyN Köhler, M Friedrich, L Gansera, et al.
Journal of Cancer Research and Clinical Oncology|January 1, 1997
Concentrations of lysosomal cysteine proteases are decreased in renal cell carcinoma compared with normal kidneyH Kirschke, T Clausen, B Göhring, et al.
Annals of Oncology : Official Journal of the European Society for Medical Oncology|May 29, 1998
Recombinant human erythropoietin in the treatment of chemotherapy-induced anemia and prevention of transfusion requirement associated with solid tumors: a randomized, controlled studyC Oberhoff, B Neri, D Amadori, et al.
Der Urologe. Ausg. A|November 3, 2020
[Certified residency curriculum for the specialization training in urology from the German Society of Urology according to the 2018 Training Regulations (version of 20. September 2019)]M S Michel, M Himmler, U Necknig, et al.
British Journal of Cancer|August 16, 2006
Interleukin-2/interferon-alpha2a/13-retinoic acid-based chemoimmunotherapy in advanced renal cell carcinoma: results of a prospectively randomised trial of the German Cooperative Renal Carcinoma Chemoimmunotherapy Group (DGCIN)J Atzpodien, H Kirchner, U Rebmann, et al.
Pageof 4